Dermata's Xyngari showed significant acne improvement in Phase 3 results. A second pivotal trial is set for the second half ...

Mucormycosis or ‘black fungus’, is a fungal infection affecting the sinuses, lungs, brain, and skin. The fungal infection is ...

Dermata Therapeutics, Inc. ("Dermata" or the "Company"), a late-stage biotechnology company focusing on the treatment of medical skin diseases and aesthetic applications, today announced positive ...

From X-ray and cancer screening to embryology and beyond, the medical world is using AI to develop new treatments, though ...

Experts at the University of Leeds have created a penny-sized rolling robot that can non-invasively capture ultrasound scans ...

Evaluation of nemvaleukin for platinum-resistant ovarian cancer will be terminated based on OS data from an interim analysis ...

On October 10, 2024, Immatics provided a data update on IMA203 monotherapy in 28 heavily pretreated metastatic melanoma ...

By Professor H. Peter Soyer and Professor Monika Jander , The University of QueenslandThe potential for 3D photography to ...

Candel Therapeutics (CADL) announced final survival data from a phase 2a clinical trial of CAN-2409 in patients with stage III/IV NSCLC, ...

Local anesthetic transperineal (LATP) biopsy is increasingly favored for prostate cancer detection due to lower infectious ...

On track for multiple clinical updates through mid-2026, including further progress from two ongoing clinical programs and initiation of ...

On track for multiple clinical updates through mid-2026, including further progress from two ongoing clinical programs and initiation of therapeutic dosing of potential new medicine, all based on our ...